|
|
|
|
|
Click Here to return To Results
|
|
|
|
In an attempt to determine the opinions and practices of neurologists regarding the use of antithrombotic drugs in the treatment of acute ischemic stroke,we conducted a survey of 349 randomly selected neurologists from throughout the United States.Responses were received from 247(71%),and 219 identified themselves as primary or consulting physicians for patients with acute ischemic stroke.During the previous 12 months,these 219 physicians estimated that they had seen a total of 14,636 patients without 24 hours of acute ischemic stroke,and 22%of these patients were treated with heparin.The most frequently reported indications were prevention of recurrent cerebral embolism(82%of physicians)and progressing stroke(70%).Despite the frequent use of heparin,only 6.4%of neurologists felt that it has been shown to be effective,and 16.4%felt that it has been shown to be of no value.The primary concern about the use of heparin was lack of proven efficacy in 48%and safety concerns in 41%.Results of a future trial testing the efficacy of antithrombotic drugs would be useful for most neurologists in their management of patients with acute or progressing ischemic stroke. |
|
(click to filter results - removes previous filter)
anticoagulant,complications of
anticoagulant,treatment
anticoagulant,treatment in CVD
cerebrovascular accident
cerebrovascular accident,acute management of
heparin
neurologic practice
treatment of neurologic disorder
|
Click Here to return To Results
|
|